Treatment-emergent mania has been reported with various selective serotonin reuptake inhibitors (SSRIs) (Diler and Avci, 1999; Grubbs, 1997) . We report four cases of citalopram-induced mania in children.
mania 13 days later that lasted 1 week. We stopped citalopram, escitalopram, and olanzapine, after which depressive symptoms with catatonia reappeared. The child was treated with sertraline 225 mg/day, electroconvulsive therapy, and behavior therapy for social phobia. After 2 months, depression and catatonia remitted, but social anxiety continued.
The manic symptoms by which DSM-IV diagnoses could be made were irritable or euphoric mood, pressure of speech, increased activity, high-energy levels, aggression, recklessness, overfamiliarity, increased socialization, grandiose ideas, and decreased need for food and sleep. In all the children, the manic symptoms temporally correlated with the use of citalopram. All improved to an extent on stopping citalopram. However, all required further treatment.
The patient in case 3 demonstrated manic symptoms with more than one SSRI. This was dose related. This has not been well documented. This case also raises the possibility that a treatment-emergent mania with one SSRI may sensitize a patient to treatment-emergent mania with lower doses of another SSRI. As demonstrated by case 3, citalopram could be used despite causing hypomania if such symptoms are controlled.
The patient in case 4 was on both citalopram and escitalopram when mania emerged, raising the possibility of escitalopram also being a reason for the same.
We corroborate the observation of Heimann and March (1996) that nonremission of the mania to stopping of SSRIs in cases 1, 2, and 3 suggests the possibility of the unmasking of a latent bipolar illness rather than a drug-induced switch. Case 4, however, suggests a citalopram-induced switch.
No child had a family history of bipolar disorder. Two had a family history of depressive disorders, raising the possibility of a predisposition to treatment-emergent mania. The patient in case 3 had hypomania with two SSRIs but no family history of a psychiatric disorder. We advocate that caution be exercised in treating depression with citalopram and escitalopram in pediatric populations even in the absence of a family history of affective illness. 
